Mesenchymal) Tissues E
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Mixed Hepatoblastoma in the Adult: Case Report and Review of the Literature
J Clin Pathol: first published as 10.1136/jcp.33.11.1058 on 1 November 1980. Downloaded from J Clin Pathol 1980;33:1058-1063 Mixed hepatoblastoma in the adult: case report and review of the literature RP HONAN AND MT HAQQANI From the Department of Pathology, Walton Hospital, Rice Lane, Liverpool L9 JAE, UK SUMMARY A case of mixed hepatoblastoma in a woman is described. A survey of the English literature reveals 13 cases acceptable as mixed hepatoblastoma; these have been described and published under a variety of names. Difficulties in nomenclature and the histology of these cases are discussed. Diagnosis depends on the identification of both malignant mesenchymal and malignant epithelial elements. The former include myxoid connective tissue resembling primitive mesenchyme and areas resembling adult fibrosarcoma. Mature fibrous tissue with calcification and bone for- mation may be seen. Epithelial areas show tissue resembling fetal liver, poorly differentiated epithelial cells, and/or areas of adenocarcinoma. The current view on histogenesis is also given. Most hepatoblastomas occur in children under the mixedtumour,6carcino-osteochondromyxosarcoma,5 copyright. age of 2 years.' Hepatoblastoma in adults is ex- and rhabdomyosarcohepatoma.7 tremely rare, and the prognosis is much worse than in the mixed hepatoblastoma of childhood. Case report The literature of mixed hepatoblastoma in adults has until recently been confused, and the true inci- CLINICAL PRESENTATION dence of the tumour obscured, owing to the various A Chinese woman aged 27 had been resident in names used by different authors to describe their England for eight years. She gave a history of cases. The commonest pseudonym is 'mixed malig- 18 months' intermittent right-sided chest pain http://jcp.bmj.com/ nant tumour',2-4 an ambivalent term which merely and upper abdominal discomfort. -
Pleomorphic Adenoma of Buccal Mucosa: a Rare Case Report
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-ISSN: 2279-0853, p-ISSN: 2279-0861.Volume 16, Issue 3 Ver. XI (March. 2017), PP 75-78 www.iosrjournals.org Pleomorphic Adenoma of Buccal Mucosa: A Rare Case Report Ashwini Jangamashetti, BDS1, Siddesh Shenoy, MDS2, R.Krishna Kumar MDS3, Amol Jeur, MS4 1Post Graduate Student, Department Of Oral Medicine And Radiology, MARDC,Pune 2Reader, Department of oral Medicine and radiology, M.A Rangoonwala Dental College and Research Center, Pune (MARDC), 3Professor and HOD, Department of oral Medicine and Radiology, MARDC, Pune 4Assistant Professor in Department of General surgery, Krishna Medical College of KIMS Deemed University , Abstract: Pleomorphic adenoma is a benign tumor of the salivary gland that consists of a combination of epithelial and mesenchymal elements1. About 90% of these tumors occur in the parotid gland and 10% in the minor salivary glands2. Among intra oral pleomorphic adenomas buccal vestibule is among the rarest sites3. A case of pleomorphic adenoma of minor salivary glands in the buccal vestibule in a 36 year-old female is discussed4. It includes review of literature, clinical features, histopathology, radiological findings and treatment of the tumor, with emphasis on diagnosis4. The mass was removed by wide local excision with adequate margins5. Keywords: minor salivary gland, pleomorphic adenoma, tumor, parotid gland, vestibule, mesenchymal elements. I. Introduction Pleomorphic adenoma (PA) is defined by World Health Organization in 1972 as a circumscribed tumor characterized by its pleomorphic or mixed appearance clearly recognizable epithelial tissue being intermingled with tissue of mucoid, myxoid and chondroid appearance2. Among all salivary gland tumors, pleomorphic adenoma is the most frequently encountered lesion accounting for approximately 60% of all salivary gland neoplasms3. -
Recurrent Targetoid Hemosiderotic Hemangioma in a 26-Year-Old Man
CASE REPORT Recurrent Targetoid Hemosiderotic Hemangioma in a 26-Year-Old Man LT Sarah Broski Gendernalik, DO, MC (FS), USN LT James D. Gendernalik, DO, MC (FS), USN A 26-year-old previously healthy man presented with a 6-mm violaceous papule that had a surrounding 1.5-cm annular, nonblanching, erythematous halo on the right-sided flank. The man reported the lesion had been recurring for 4 to 5 years, flaring every 4 to 5 months and then slowly disap - pearing until the cycle recurred. Targetoid hemosiderotic hemangioma was clinically diagnosed. The lesion was removed by means of elliptical excision and the condition resolved. The authors discuss the clinical appearance, his - tology, and etiology of targetoid hemosiderotic heman - giomas. J Am Osteopath Assoc . 2011;111(2);117-118 argetoid hemosiderotic hemangiomas (THHs) are a com - Tmonly misdiagnosed presentation encountered in the primary care setting. In the present case report, we aim to pro - Figure. A 6-mm violaceous papule with a surrounding 1.5-cm annular, nonblanching, erythematous halo in a 26-year-old man. vide general practitioners with an understanding of the clin - ical appearance, pathology, and prognosis of THH. Report of Case A 26-year-old previously healthy man presented to our primary around it and itched and burned each time it developed. The care clinic with a 6-mm violaceous papule with a surrounding lesion faded completely to normal-appearing skin between 1.5-cm annular, nonblanching, erythematous halo on the right- episodes, without evidence of a papule or postinflammatory sided flank ( Figure ). The patient stated that the lesion had hyperpigmentation. -
Angiokeratoma of the Scrotum (Fordyce Type) Associated with Angiokeratoma of the Oral Cavity
208 Letters to the Editor anti-thyroperoxidas e antibody in addition to, or, less Yamada A. Antineutrophil cytoplasmic autoantibody- likely, instead of MPO-ANCA cannot be excluded. positive crescentric glomerulonephritis associated with thi- amazole therapy. Nephron 1996; 74: 734–735. Vesiculo-bullous SLE has been reported to respond 6. Cooper D. Antithyroid drugs. N Engl J Med 1984; 311: to dapsone (15). However, in our patient, an early 1353–1362. aggressive treatment with steroid pulse therapy and 7. Yung RL, Richardson BC. Drug-induced lupus. Rheum plasmapheresis was mandatory because of her life- Dis Clin North Am 1994; 20: 61–86. threatening clinical condition. The contributory factors, 8. Hess E. Drug-related lupus. N Engl J Med 1988; 318: 1460–1462. such as an environmental trigger or an immunological 9. Sato-Matsumura KC, Koizumi H, Matsumura T, factor, for the presence of a serious illness in this patient Takahashi T, Adachi K, Ohkawara A. Lupus eryth- remain to be elucidated. The mechanism by which ematosus-like syndrome induced by thiamazole and methimazole induces SLE-like reactions is unclear. propylthiouracil. J Dermatol 1994; 21: 501–507. 10. Wing SS, Fantus IG. Adverse immunologic eVects of antithyroid drugs. Can Med Assoc J 1987; 136: 121–127. 11. Condon C, Phelan M, Lyons JF. Penicillamine-induced REFERENCES type II bullous systemic lupus erythematosus. Br J Dermatol 1997; 136: 474–475. 1. Alarcon-Segovia D. Drug induced lupus syndromes. Mayo 12. Stankus S, Johnson N. Propylthiouracil-induced hyper- Clin Proc 1969; 44: 664–681.2. sensitivity vasculitis presenting as respiratory failure. Chest 2. Cush JJ, Goldings EA. -
Soft Tissue Cytopathology: a Practical Approach Liron Pantanowitz, MD
4/1/2020 Soft Tissue Cytopathology: A Practical Approach Liron Pantanowitz, MD Department of Pathology University of Pittsburgh Medical Center [email protected] What does the clinician want to know? • Is the lesion of mesenchymal origin or not? • Is it begin or malignant? • If it is malignant: – Is it a small round cell tumor & if so what type? – Is this soft tissue neoplasm of low or high‐grade? Practical diagnostic categories used in soft tissue cytopathology 1 4/1/2020 Practical approach to interpret FNA of soft tissue lesions involves: 1. Predominant cell type present 2. Background pattern recognition Cell Type Stroma • Lipomatous • Myxoid • Spindle cells • Other • Giant cells • Round cells • Epithelioid • Pleomorphic Lipomatous Spindle cell Small round cell Fibrolipoma Leiomyosarcoma Ewing sarcoma Myxoid Epithelioid Pleomorphic Myxoid sarcoma Clear cell sarcoma Pleomorphic sarcoma 2 4/1/2020 CASE #1 • 45yr Man • Thigh mass (fatty) • CNB with TP (DQ stain) DQ Mag 20x ALT –Floret cells 3 4/1/2020 Adipocytic Lesions • Lipoma ‐ most common soft tissue neoplasm • Liposarcoma ‐ most common adult soft tissue sarcoma • Benign features: – Large, univacuolated adipocytes of uniform size – Small, bland nuclei without atypia • Malignant features: – Lipoblasts, pleomorphic giant cells or round cells – Vascular myxoid stroma • Pitfalls: Lipophages & pseudo‐lipoblasts • Fat easily destroyed (oil globules) & lost with preparation Lipoma & Variants . Angiolipoma (prominent vessels) . Myolipoma (smooth muscle) . Angiomyolipoma (vessels + smooth muscle) . Myelolipoma (hematopoietic elements) . Chondroid lipoma (chondromyxoid matrix) . Spindle cell lipoma (CD34+ spindle cells) . Pleomorphic lipoma . Intramuscular lipoma Lipoma 4 4/1/2020 Angiolipoma Myelolipoma Lipoblasts • Typically multivacuolated • Can be monovacuolated • Hyperchromatic nuclei • Irregular (scalloped) nuclei • Nucleoli not typically seen 5 4/1/2020 WD liposarcoma Layfield et al. -
Tumors and Tumor-Like Lesions of Blood Vessels 16 F.Ramon
16_DeSchepper_Tumors_and 15.09.2005 13:27 Uhr Seite 263 Chapter Tumors and Tumor-like Lesions of Blood Vessels 16 F.Ramon Contents 42]. There are two major classification schemes for vas- cular tumors. That of Enzinger et al. [12] relies on 16.1 Introduction . 263 pathological criteria and includes clinical and radiolog- 16.2 Definition and Classification . 264 ical features when appropriate. On the other hand, the 16.2.1 Benign Vascular Tumors . 264 classification of Mulliken and Glowacki [42] is based on 16.2.1.1 Classification of Mulliken . 264 endothelial growth characteristics and distinguishes 16.2.1.2 Classification of Enzinger . 264 16.2.1.3 WHO Classification . 265 hemangiomas from vascular malformations. The latter 16.2.2 Vascular Tumors of Borderline classification shows good correlation with the clinical or Intermediate Malignancy . 265 picture and imaging findings. 16.2.3 Malignant Vascular Tumors . 265 Hemangiomas are characterized by a phase of prolif- 16.2.4 Glomus Tumor . 266 eration and a stationary period, followed by involution. 16.2.5 Hemangiopericytoma . 266 Vascular malformations are no real tumors and can be 16.3 Incidence and Clinical Behavior . 266 divided into low- or high-flow lesions [65]. 16.3.1 Benign Vascular Tumors . 266 Cutaneous and subcutaneous lesions are usually 16.3.2 Angiomatous Syndromes . 267 easily diagnosed and present no significant diagnostic 16.3.3 Hemangioendothelioma . 267 problems. On the other hand, hemangiomas or vascular 16.3.4 Angiosarcomas . 268 16.3.5 Glomus Tumor . 268 malformations that arise in deep soft tissue must be dif- 16.3.6 Hemangiopericytoma . -
Well-Differentiated Spindle Cell Liposarcoma
Modern Pathology (2010) 23, 729–736 & 2010 USCAP, Inc. All rights reserved 0893-3952/10 $32.00 729 Well-differentiated spindle cell liposarcoma (‘atypical spindle cell lipomatous tumor’) does not belong to the spectrum of atypical lipomatous tumor but has a close relationship to spindle cell lipoma: clinicopathologic, immunohistochemical, and molecular analysis of six cases Thomas Mentzel1, Gabriele Palmedo1 and Cornelius Kuhnen2 1Dermatopathologie, Friedrichshafen, Germany and 2Institute of Pathology, Medical Center, Mu¨nster, Germany Well-differentiated spindle cell liposarcoma represents a rare atypical/low-grade malignant lipogenic neoplasm that has been regarded as a variant of atypical lipomatous tumor. However, well-differentiated spindle cell liposarcoma tends to occur in subcutaneous tissue of the extremities, the trunk, and the head and neck region, contains slightly atypical spindled tumor cells often staining positively for CD34, and lacks an amplification of MDM2 and/or CDK4 in most of the cases analyzed. We studied a series of well-differentiated spindle cell liposarcomas arising in two female and four male patients (age of the patients ranged from 59 to 85 years). The neoplasms arose on the shoulder, the chest wall, the thigh, the lower leg, the back of the hand, and in paratesticular location. The size of the neoplasms ranged from 1.5 to 10 cm (mean: 6.0 cm). All neoplasms were completely excised. The neoplasms were confined to the subcutis in three cases, and in three cases, an infiltration of skeletal muscle was seen. Histologically, the variably cellular neoplasms were composed of atypical lipogenic cells showing variations in size and shape, and spindled tumor cells with slightly enlarged, often hyperchromatic nuclei. -
Diagnostic Immunohistochemistry for Canine Cutaneous Round Cell Tumours — Retrospective Analysis of 60 Cases
FOLIA HISTOCHEMICA ORIGINAL PAPER ET CYTOBIOLOGICA Vol. 57, No. 3, 2019 pp. 146–154 Diagnostic immunohistochemistry for canine cutaneous round cell tumours — retrospective analysis of 60 cases Katarzyna Pazdzior-Czapula, Mateusz Mikiewicz, Michal Gesek, Cezary Zwolinski, Iwona Otrocka-Domagala Department of Pathological Anatomy, Faculty of Veterinary Medicine, University of Warmia and Mazury in Olsztyn, Olsztyn, Poland Abstract Introduction. Canine cutaneous round cell tumours (CCRCTs) include various benign and malignant neoplastic processes. Due to their similar morphology, the diagnosis of CCRCTs based on histopathological examination alone can be challenging, often necessitating ancillary immunohistochemical (IHC) analysis. This study presents a retrospective analysis of CCRCTs. Materials and methods. This study includes 60 cases of CCRCTs, including 55 solitary and 5 multiple tumours, evaluated immunohistochemically using a basic antibody panel (MHCII, CD18, Iba1, CD3, CD79a, CD20 and mast cell tryptase) and, when appropriate, extended antibody panel (vimentin, desmin, a-SMA, S-100, melan-A and pan-keratin). Additionally, histochemical stainings (May-Grünwald-Giemsa and methyl green pyronine) were performed. Results. IHC analysis using a basic antibody panel revealed 27 cases of histiocytoma, one case of histiocytic sarcoma, 18 cases of cutaneous lymphoma of either T-cell (CD3+) or B-cell (CD79a+) origin, 5 cases of plas- macytoma, and 4 cases of mast cell tumours. The extended antibody panel revealed 2 cases of alveolar rhabdo- myosarcoma, 2 cases of amelanotic melanoma, and one case of glomus tumour. Conclusions. Both canine cutaneous histiocytoma and cutaneous lymphoma should be considered at the beginning of differential diagnosis for CCRCTs. While most poorly differentiated CCRCTs can be diagnosed immunohis- tochemically using 1–4 basic antibodies, some require a broad antibody panel, including mesenchymal, epithelial, myogenic, and melanocytic markers. -
The Health-Related Quality of Life of Sarcoma Patients and Survivors In
Cancers 2020, 12 S1 of S7 Supplementary Materials The Health-Related Quality of Life of Sarcoma Patients and Survivors in Germany—Cross-Sectional Results of A Nationwide Observational Study (PROSa) Martin Eichler, Leopold Hentschel, Stephan Richter, Peter Hohenberger, Bernd Kasper, Dimosthenis Andreou, Daniel Pink, Jens Jakob, Susanne Singer, Robert Grützmann, Stephen Fung, Eva Wardelmann, Karin Arndt, Vitali Heidt, Christine Hofbauer, Marius Fried, Verena I. Gaidzik, Karl Verpoort, Marit Ahrens, Jürgen Weitz, Klaus-Dieter Schaser, Martin Bornhäuser, Jochen Schmitt, Markus K. Schuler and the PROSa study group Includes Entities We included sarcomas according to the following WHO classification. - Fletcher CDM, World Health Organization, International Agency for Research on Cancer, editors. WHO classification of tumours of soft tissue and bone. 4th ed. Lyon: IARC Press; 2013. 468 p. (World Health Organization classification of tumours). - Kurman RJ, International Agency for Research on Cancer, World Health Organization, editors. WHO classification of tumours of female reproductive organs. 4th ed. Lyon: International Agency for Research on Cancer; 2014. 307 p. (World Health Organization classification of tumours). - Humphrey PA, Moch H, Cubilla AL, Ulbright TM, Reuter VE. The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs—Part B: Prostate and Bladder Tumours. Eur Urol. 2016 Jul;70(1):106–19. - World Health Organization, Swerdlow SH, International Agency for Research on Cancer, editors. WHO classification of tumours of haematopoietic and lymphoid tissues: [... reflects the views of a working group that convened for an Editorial and Consensus Conference at the International Agency for Research on Cancer (IARC), Lyon, October 25 - 27, 2007]. 4. ed. -
Lymphangioma Circumscriptum of the Vulva- a Case Series Dermatology Section
DOI: 10.7860/JCDR/2021/47435.14553 Case Series Lymphangioma Circumscriptum of the Vulva- A Case Series Dermatology Section RASHMI S MAHAJAN1, YOGESH S MARFATIA2, ATMAKALYANI R SHAH3, KISHAN R NINAMA4 ABSTRACT Vulval dermatoses pose a diagnostic and therapeutic challenge for the dermatologists. Lymphangioma Circumscriptum (LC) is a form of lymphangioma affecting the skin and subcutaneous tissues that is characterised by benign dilation of lymphatic channels. This uncommon condition is known to occur over the chest, mouth, axilla, tongue, and rarely in the vulva. In this series, authors present three cases of LC of vulva in women between the age group of 45 to 60 years with late-onset fluid-filled lesions over the vulva. The first case had history of hysterectomy prior to onset of lesions, the second case had a spontaneous onset of lesions while the third was a suspected case of pelvic tuberculosis with secondary lymphangioma. Keywords: Lymphangiectasia, Vulvar, Vulval epithelium INTRODUCTION Disorders of vulval epithelium are a confusing spectrum of disorders. They are broadly classified as-1) Inflammatory, 2) Ulcerative and Bullous, 3) Infections, 4) Benign tumours and 5) Malignancies. It is essential to know the exact aetiology to plan successful therapy. LC is a benign lymphatic malformation characterised by dilation of lymphatic vessels in the skin and subcutaneous tissue with lesions erupting locally as isolated or grouped translucid, thin-walled vesicles filled with a clear liquid [1]. These pathological lymphatic malformations have no communication with the normal lymphatics [2]. The precise cause of LC is not established. It could be congenital or acquired as a result of damage to the lymphatic vessels secondary to various aetiologies. -
Angiokeratoma of the Scrotum (Fordyce)
Keio Journal of Medicine Vol. 1, No. 1, January, 1952 ANGIOKERATOMA OF THE SCROTUM (FORDYCE) MASAKATSU IZAKI Department of Dermatology, School of Medicine, Keio University Since Fordyce, in 1896, first described a case of angiokeratoma of the scrotum, many authors have reported and discussed about this dermatosis. However the classification and the nomenclature of this skin disease still remain in a state of confusion. Recently I had a chance to see the report of Robinson and Tasker (1946)(14), discussing the nomenclature of this condition, which held my attention considerably. In this paper I wish to report statistical observation concerning the incidences of this dermatosis among Japanese males, and histopathological studies made in 5 cases of this condition. STATISTICALOBSERVATION It must be first pointed out that this study was made along with the statistical study on angioma senile and same persons were examined in both dermatosis (ref. Studies on Senile Changes in the Skin I. Statistical Observation; Journal of the Keio Medical Society Vol. 28, No. 2, p. 59, 1951). The statistics was handled by the small sampling method. Totals of persons examined were 1552 males. Their ages varied from 16 to 84 years, divided into seven groups: i.e. the late teen-agers (16-20), persons of the third decade (21-30), of the fourth decade (31-40), of the fifth decade (41-50), of the sixth decade (51-60), of the seventh decade (61-70) and a group of persons over 71 years of age. The number of persons and the incidence of this condition in each group are summarized briefly in Table 1. -
Radiation-Associated Synovial Sarcoma
Radiation-Associated Synovial Sarcoma: Clinicopathologic and Molecular Analysis of Two Cases Jean-François Egger, M.D., Jean-Michel Coindre, M.D., Jean Benhattar, Ph.D., Philippe Coucke, M.D., Louis Guillou, M.D. University Institute of Pathology (J-FE, JB, LG) and Department of Radiooncology, University Hospital (PC), Lausanne, Switzerland; Bergonié Institute and University of Bordeaux II (J-MC), Bordeaux, France region, or viscera (1, 2). SS bears the t(X;18) (SYT- Development of a soft-tissue sarcoma is an infre- SSX) reciprocal translocation that seems to be spe- quent but well-known long-term complication of cific for this tumor type and can be routinely de- radiotherapy. Malignant fibrous histiocytomas, ex- tected in paraffin-embedded tissue using the traskeletal osteosarcomas, fibrosarcomas, malig- reverse transcriptase–polymerase chain reaction nant peripheral nerve sheath tumors, and angiosar- (RT-PCR; 3–6). Radiation-associated sarcomas are comas are most frequently encountered. Radiation- an infrequent but well-known long-term complica- associated synovial sarcomas are exceptional. We tion of radiotherapy (7–16). They occur in about report the clinicopathologic, immunohistochemi- 1/1000 patients who have undergone radiation cal, and molecular features of two radiation- therapy (7–11). Radiation-associated sarcomas are associated synovial sarcomas. One tumor developed defined as sarcomas arising in a previously irradi- in a 42-year-old female 17 years after external irra- ated field after a latency period of Ն2 years (12). diation was given for breast carcinoma; the other They usually show a more aggressive clinical course occurred in a 34-year-old female who was irradiated associated with shortened patient survival as com- at the age of 7 years for a nonneoplastic condition of pared with sporadic sarcomas (9–12, 14).